A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei.
about
Animal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal RuleProphylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosisStrategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.CRISPLD2 is expressed at low levels during septic shock and is associated with procalcitoninBurkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosisProphylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols.Present and future therapeutic strategies for melioidosis and glanders.The impact of "omic" and imaging technologies on assessing the host immune response to biodefence agents.Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei.Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.Gene expression profiles identify both MyD88-independent and MyD88-dependent pathways involved in the maturation of dendritic cells mediated by heparan sulfate: a novel adjuvant.iNOS activity is critical for the clearance of Burkholderia mallei from infected RAW 264.7 murine macrophages.Antiinfective applications of toll-like receptor 9 agonists.Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection.Protection from pneumonic infection with burkholderia species by inhalational immunotherapyMonitoring Therapeutic Treatments against Burkholderia Infections Using Imaging TechniquesProtective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge.Targeting the "cytokine storm" for therapeutic benefit.One-Shot Immunomodulatory Nanodiamond Agents for Cancer Immunotherapy.Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding.
P2860
Q26859041-9FC2E796-E9C3-4020-B1FD-DEE62FA1BF16Q27305350-DE5F9A1C-8369-4E6F-B1D5-00B6DF90AC79Q28299584-7B8070E6-EC64-43E9-A233-CC220492415FQ30424747-5C165069-7BA6-444A-8D8B-B8B235793979Q31120386-8FFAB274-71A0-410F-BCAF-1324A6431117Q33278807-F931C54F-362E-4242-AAA1-D6B98B73CD24Q33676552-E603A13E-D6D7-4165-A43A-B00D41B45322Q33698285-E0AE6DED-C227-4BDF-B013-DB974090E6F7Q33797791-BF67C87F-526F-44F0-8EE1-270515149070Q34275632-1011309E-8DDA-4F49-862D-8F841BB9A45BQ35073768-EA3D17F7-3F0A-4DAC-AE88-AF7A4B5B3375Q35129390-8FCC0582-2C44-4519-BCA8-E7E695F6394EQ35886513-4C7947DD-0693-4DB2-8AA3-040A09BC79A7Q36433193-5DD26413-611A-4832-BD47-4379B20793BBQ36868322-A47BC14D-E019-4F02-BB74-BF04E1024B4FQ36911486-855ECA06-CBD4-4D41-82E0-312FE026FC42Q37145069-87C8E56C-63FF-4AF7-8817-C1563742720AQ37384332-5EDA2B7D-8962-410C-BEAE-9A43B044913DQ37417238-5BA8569D-62C9-4A0B-A3B8-B0697BCD7FA7Q38071254-E872A951-E349-4578-BF26-0C609F970C68Q38797466-E9C421F7-28F4-479A-9F41-BE9A9B380D02Q38890754-B5C08394-0729-4484-8E0E-D976991471DCQ39182856-D1C4EA0A-71C6-47EC-9065-41CD33510976
P2860
A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A CpG oligonucleotide can prot ...... e dose of Burkholderia mallei.
@ast
A CpG oligonucleotide can prot ...... e dose of Burkholderia mallei.
@en
A CpG oligonucleotide can prot ...... e dose of Burkholderia mallei.
@nl
type
label
A CpG oligonucleotide can prot ...... e dose of Burkholderia mallei.
@ast
A CpG oligonucleotide can prot ...... e dose of Burkholderia mallei.
@en
A CpG oligonucleotide can prot ...... e dose of Burkholderia mallei.
@nl
prefLabel
A CpG oligonucleotide can prot ...... e dose of Burkholderia mallei.
@ast
A CpG oligonucleotide can prot ...... e dose of Burkholderia mallei.
@en
A CpG oligonucleotide can prot ...... e dose of Burkholderia mallei.
@nl
P2093
P2860
P1476
A CpG oligonucleotide can prot ...... e dose of Burkholderia mallei.
@en
P2093
Arthur M Krieg
David M Waag
Michael J McCluskie
Ningli Zhang
P2860
P304
P356
10.1128/IAI.74.3.1944-1948.2006
P407
P577
2006-03-01T00:00:00Z